LI
GRTS

Leap Investments’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Leap Investments’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14,400
Closed -$84K – 597
2020
Q1 		$84K Buy
+14,400
New +$121K 0.12% 287

Other funds holding GRTS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Leap Investments's GRTS Position: Q2 2020 in Review

Leap Investments sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2020, closing a stake of 14,400 shares — an estimated $84K sold.

Leap Investments first reported a position in GRTS in Q1 2020 and held it in 1 quarter. The position peaked at $84K in Q1 2020. 81 funds tracked by Wall St. Rank hold GRTS as of Q2 2020.

  • Leap Investments reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Leap Investments sold 14,400 Gritstone bio, Inc. Common Stock shares in Q2 2020, an estimated $84K.
  • Leap Investments first reported a position in Gritstone bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Leap Investments's Gritstone bio, Inc. Common Stock position peaked at $84K in Q1 2020.
  • 81 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.